SG10201701670SA - Compositions of aquatic origin for prevention of cell adhesion and methods of using same - Google Patents

Compositions of aquatic origin for prevention of cell adhesion and methods of using same

Info

Publication number
SG10201701670SA
SG10201701670SA SG10201701670SA SG10201701670SA SG10201701670SA SG 10201701670S A SG10201701670S A SG 10201701670SA SG 10201701670S A SG10201701670S A SG 10201701670SA SG 10201701670S A SG10201701670S A SG 10201701670SA SG 10201701670S A SG10201701670S A SG 10201701670SA
Authority
SG
Singapore
Prior art keywords
prevention
compositions
methods
same
cell adhesion
Prior art date
Application number
SG10201701670SA
Other languages
English (en)
Inventor
Amir Zlotkin
Eliahu Zlotkin
Original Assignee
Tel Hashomer Medical Res Infrastructure & Services Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tel Hashomer Medical Res Infrastructure & Services Ltd filed Critical Tel Hashomer Medical Res Infrastructure & Services Ltd
Publication of SG10201701670SA publication Critical patent/SG10201701670SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
SG10201701670SA 2007-09-20 2008-09-21 Compositions of aquatic origin for prevention of cell adhesion and methods of using same SG10201701670SA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US96021407P 2007-09-20 2007-09-20

Publications (1)

Publication Number Publication Date
SG10201701670SA true SG10201701670SA (en) 2017-04-27

Family

ID=40468563

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201701670SA SG10201701670SA (en) 2007-09-20 2008-09-21 Compositions of aquatic origin for prevention of cell adhesion and methods of using same
SG2013066063A SG193848A1 (en) 2007-09-20 2008-09-21 Compositions of aquatic origin for prevention of cell adhesion and methods of using same

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2013066063A SG193848A1 (en) 2007-09-20 2008-09-21 Compositions of aquatic origin for prevention of cell adhesion and methods of using same

Country Status (9)

Country Link
US (1) US9737571B2 (fr)
EP (1) EP2197390B1 (fr)
JP (2) JP5823692B2 (fr)
KR (3) KR20140068238A (fr)
CN (1) CN101835668A (fr)
AU (1) AU2008300156B2 (fr)
CA (1) CA2700256C (fr)
SG (2) SG10201701670SA (fr)
WO (1) WO2009037714A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5548121B2 (ja) 2007-05-14 2014-07-16 リサーチ ファウンデーション オブ ステイト ユニバーシティ オブ ニューヨーク バイオフィルム中の細菌細胞における生理学的分散応答の誘導
ES2690348T3 (es) * 2008-09-24 2018-11-20 Tel Hashomer Medical Research Infrastructure And Services Ltd. Péptidos y composiciones para la prevención de la adhesión celular y métodos de uso de los mismos
DE102008060844A1 (de) * 2008-12-06 2010-06-17 Christian-Albrechts-Universität Zu Kiel Antimikrobielle Peptide aus Hydra
US8552147B2 (en) * 2008-12-29 2013-10-08 Tel Hashomer Medical Research, Infrastructure And Services Ltd. Peptides and compositions for prevention of cell adhesion and methods of using same
US11174299B2 (en) 2008-12-29 2021-11-16 Dispersebio Ltd. Peptides and compositions for prevention of cell adhesion and methods of using same
SG10201604103SA (en) * 2011-05-31 2016-07-28 Hutchison Biofilm Medical Solutions Ltd Dispersion and detachment of cell aggregates
US8551532B2 (en) 2011-11-02 2013-10-08 Kuwait University Method of making an anti-inflammatory composition
CN104231105B (zh) * 2014-09-28 2016-06-22 浙江工业大学 一种海葵多糖的制备方法及其抗肿瘤应用
CN105918200B (zh) * 2016-04-29 2021-04-02 常州市金坛区水产技术指导站 一种蟹稻共生种养池及其综合调温方法
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
CN110025775B (zh) * 2019-05-14 2020-04-28 连云港诗碧曼生物科技有限公司 一种温和固发的防脱发生发精华液及其制备方法
CN118546822B (zh) * 2024-05-16 2025-02-07 烟台大学 一株具有抑制灾害水母螅状体无性生殖的副蕈状芽孢杆菌及其应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697285A (en) 1969-10-10 1972-10-10 Rohm & Haas Fish protein solubilization using alkaline bacterial protease
US4286988A (en) 1980-06-30 1981-09-01 The United States Of America As Represented By The Secretary Of The Navy Copper base antifouling paints with pH control
US4678512A (en) 1982-02-12 1987-07-07 Grams Ralph R Marine coating compositions and method
GB8511144D0 (en) 1985-05-02 1985-06-12 Int Paint Plc Marine anti-fouling paint
US4865909A (en) 1987-10-21 1989-09-12 W. L. Gore & Associates, Inc. Microporous anti-fouling marine coating
US5410023A (en) * 1989-06-27 1995-04-25 Burzio; Luis O. Peptide useful as adhesive, and process for the preparation thereof
JPH054903A (ja) * 1990-10-30 1993-01-14 Nkk Corp 貝類足糸付着阻害剤及びその製造方法
JPH0544903A (ja) * 1991-08-20 1993-02-23 Mitsubishi Heavy Ind Ltd ボイラの伸縮継手
US5143545A (en) 1991-09-20 1992-09-01 The United States Of America As Represented By The Secretary Of The Navy Antifouling marine coatings
JPH05156088A (ja) * 1991-12-02 1993-06-22 Yokohama Rubber Co Ltd:The 防汚エラストマー組成物
CN1096426A (zh) * 1994-03-28 1994-12-21 王大为 鳗鱼营养液及其系列保健饮品的生产方法
JPH08193097A (ja) * 1995-01-13 1996-07-30 Tokyo Electric Power Co Inc:The 生物忌避タンパク質及びその固定化方法
AU6261499A (en) * 1998-09-23 2000-04-10 Phycogen, Inc. Antifouling agents
KR100386417B1 (ko) * 2000-08-31 2003-06-02 주식회사 내비켐 해조류의 추출물을 이용한 환경 친화적인 방오제
WO2003092382A1 (fr) * 2002-04-30 2003-11-13 Danish Institute For Fisheries Research Composition et procede pour reguler l'adherence microbienne a la formation de biofilms sur des surfaces
WO2005109960A2 (fr) * 2004-04-30 2005-11-17 Bruno Cynthia K Proprietes antagonistes de microflore de poisson de recifs
JP4786149B2 (ja) * 2004-06-30 2011-10-05 利江 土屋 ギャップ機能抑制剤、細胞増殖促進剤及び硫酸化ポリフコース
AU2005294124B2 (en) * 2004-10-07 2012-02-23 Bachem Biosciences, Inc. Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels
CA2589355A1 (fr) * 2004-12-06 2005-12-06 Surmodics, Inc. Articles medicaux multifonctionnels

Also Published As

Publication number Publication date
JP5823692B2 (ja) 2015-11-25
SG193848A1 (en) 2013-10-30
EP2197390A4 (fr) 2013-08-21
JP2014074077A (ja) 2014-04-24
KR20100093030A (ko) 2010-08-24
AU2008300156A1 (en) 2009-03-26
WO2009037714A2 (fr) 2009-03-26
US20110119774A1 (en) 2011-05-19
CA2700256C (fr) 2020-09-22
US9737571B2 (en) 2017-08-22
CN101835668A (zh) 2010-09-15
KR20140068238A (ko) 2014-06-05
AU2008300156B2 (en) 2014-10-30
CA2700256A1 (fr) 2009-03-26
JP2010540431A (ja) 2010-12-24
EP2197390A2 (fr) 2010-06-23
WO2009037714A3 (fr) 2010-03-04
KR20140068239A (ko) 2014-06-05
KR101623991B1 (ko) 2016-05-25
EP2197390B1 (fr) 2019-11-13

Similar Documents

Publication Publication Date Title
SG10201701670SA (en) Compositions of aquatic origin for prevention of cell adhesion and methods of using same
SG10201504623VA (en) Peptides and compositions for prevention of cell adhesion and methods of using same
IL206225A0 (en) Compositions and methods of detecting tiabs
IL202406A0 (en) Methods and compositions for inhibiting cd32b expressing cells
SG10201401054YA (en) Peptides and compositions for prevention of cell adhesion and methods of using same
EP2334185A4 (fr) Compositions et procédés employant du (r)-pramipexole
PT2101766T (pt) Composições e métodos de utilização de (r)-pramipexole
IL202329A0 (en) Methods and compositions for stimulating cells
ZA201001300B (en) Antigen-asjuvant compositions and methods
HRP20160902T1 (hr) Pripravci i postupci uporabe forbolskih estera
PL2069467T3 (pl) Kompozycje wydzielające i sposoby stosowania
PL2101766T3 (pl) Kompozycje i sposoby stosowania (R)-pramipeksolu
GB0721291D0 (en) Methods and compositions
EP2142926A4 (fr) Compositions et procédés de détection
IL207827A0 (en) Apoaequorin-containing compositions and methods of using same
GB0719526D0 (en) Compositions and methods
PT2264060E (pt) Composições e processos para inibição da adesão viral
PL3494960T3 (pl) Stabilizowane kompozycje środków alkilujących i sposoby ich zastosowania
ZA201004894B (en) Nuctraceutical composition and methods of use
IL204645A0 (en) Compositions of aquatic origin for prevention of cell adhesion and methods of using same
ZA201004893B (en) Nuctraceutical composition and methods of use
IL192588A0 (en) Cryoprotective compositions and methods of using same
ZA200806601B (en) Cryoprotective compositions and methods of using same
GB0717683D0 (en) Compositions and methods
GB0723775D0 (en) Methods and compositions